November 13, 2014 / 10:31 AM / 6 years ago

India's Sun Pharma Q2 profit up 15 pct, but lags estimates

MUMBAI, Nov 13 (Reuters) - Sun Pharmaceutical Industries Ltd , India’s largest drugmaker by revenue, reported a 15 percent jump in second-quarter net profit on Thursday, but slightly lagged estimates.

Net income for the quarter ended September was 15.72 billion rupees ($255.4 million), up from 13.62 billion rupees a year earlier. Analysts on average expected net income of 15.88 billion rupees, according to Thomson Reuters I/B/E/S.

Sun Pharma, which is in the process of acquiring rival drugmaker Ranbaxy Laboratories Ltd, is awaiting approval from India’s antitrust regulator for the deal. (1 US dollar = 61.5600 Indian rupee) (Reporting by Zeba Siddiqui in Mumbai; Editing by Prateek Chatterjee)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below